SCHEMBL8304589

SCHEMBL8304589

CC(=NOCCO)c1ccc(C(F)(F)F)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARA Q07869 4/20 0.55
PPARG P37231 3/20 0.55
LMNA P02545 4/20 0.47
SMN1; SMN2 Q16637 3/20 0.47
PTBP1 P26599 1/20 0.47
S1PR1 P21453 2/20 0.46
CYP1A2 P05177 2/20 0.45
CYP3A4 P08684 2/20 0.45
CYP2D6 P10635 2/20 0.45
CYP2C9 P11712 2/20 0.45
CYP2C19 P33261 2/20 0.45
HIF1A Q16665 2/20 0.45
MEN1 O00255 2/20 0.45
KMT2A Q03164 2/20 0.45
NFKB1 P19838 1/20 0.45
SLC6A2 P23975 1/20 0.45
SLC6A4 P31645 1/20 0.45
ADRA1A P35348 1/20 0.45
OPRK1 P41145 1/20 0.45
SLC6A3 Q01959 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8304871 0.95 PPARG (0.52) PPARAPPARGLMNASMN1; SMN2PTBP1
SCHEMBL8304869 0.95 PPARG (0.52) PPARAPPARGLMNASMN1; SMN2PTBP1
SCHEMBL14418609 0.86 SLC6A4 (0.60) PPARAPPARGLMNASMN1; SMN2PTBP1
SCHEMBL17577932 0.80 PPARA (0.51) PPARAPPARGLMNASMN1; SMN2PTBP1
SCHEMBL6816545 0.78 CES2 (0.45) PPARAPPARGLMNASMN1; SMN2PTBP1
SCHEMBL2056188 0.78 CES2 (0.45) PPARAPPARGLMNASMN1; SMN2PTBP1
SCHEMBL4476867 0.78 LMNA (0.69) PPARAPPARGLMNASMN1; SMN2PTBP1
SCHEMBL4476864 0.78 LMNA (0.69) PPARAPPARGLMNASMN1; SMN2PTBP1
SCHEMBL5609892 0.77 LMNA (0.65) PPARAPPARGLMNASMN1; SMN2PTBP1
SCHEMBL5609899 0.77 LMNA (0.65) PPARAPPARGLMNASMN1; SMN2PTBP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0708098-B1 Oxime derivatives, their preparation and their therapeutic use SANKYO CO (JP) 1999-03-03 EP disclosed
EP-0708098-A1 Oxime derivatives, their preparation and their therapeutic use SANKYO COMPANY LIMITED (JP) 1996-04-24 EP disclosed